BRUNELLI, Matteo
 Distribuzione geografica
Continente #
EU - Europa 9750
NA - Nord America 9084
AS - Asia 2814
OC - Oceania 24
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 5
Totale 21707
Nazione #
US - Stati Uniti d'America 8862
GB - Regno Unito 4151
CN - Cina 2569
IT - Italia 1151
SE - Svezia 1108
FR - Francia 923
IE - Irlanda 920
DE - Germania 628
FI - Finlandia 388
CA - Canada 219
UA - Ucraina 203
BE - Belgio 107
VN - Vietnam 93
RU - Federazione Russa 86
TR - Turchia 66
NL - Olanda 28
AU - Australia 22
IR - Iran 21
IN - India 19
AT - Austria 11
CL - Cile 10
JP - Giappone 9
ES - Italia 8
EU - Europa 8
HK - Hong Kong 7
PL - Polonia 6
CH - Svizzera 5
IL - Israele 5
BR - Brasile 4
CZ - Repubblica Ceca 4
LV - Lettonia 4
SG - Singapore 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
CM - Camerun 2
EG - Egitto 2
KR - Corea 2
MK - Macedonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AR - Argentina 1
BD - Bangladesh 1
CR - Costa Rica 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 21707
Città #
Southend 3738
Chandler 2286
Jacksonville 1328
Woodbridge 1067
Ann Arbor 960
Dublin 911
Houston 447
Beijing 430
Lawrence 367
Princeton 367
Wilmington 345
Jinan 330
Verona 252
Nanjing 244
Shenyang 224
Ashburn 204
Montréal 195
Munich 180
Mcallen 179
Hebei 175
Dearborn 131
Tianjin 128
Zhengzhou 119
Redmond 118
Brussels 106
Ningbo 102
Taizhou 93
Changsha 92
Haikou 86
Bologna 79
Nanchang 79
Redwood City 74
Guangzhou 69
Taiyuan 69
Lancaster 66
Jiaxing 65
Hangzhou 62
Dong Ket 57
Norwalk 51
Milan 49
Volga 47
Fairfield 38
Lanzhou 37
Rome 35
Detroit 33
Boardman 31
Chicago 31
Falls Church 29
Düsseldorf 28
Fuzhou 27
San Francisco 23
Augusta 19
Seattle 17
San Mateo 16
Cambridge 13
Helsinki 13
Toronto 13
Ardabil 11
Vienna 11
Clearwater 10
Pozza 10
Bolzano 9
Los Angeles 9
Groningen 8
Leawood 8
Nürnberg 8
Palermo 8
Qingdao 8
Riva 8
San Diego 8
Saint Louis 7
Torino 7
Buffalo 6
Canberra 6
Legnaro 6
San Donà Di Piave 6
Shanghai 6
Sydney 6
Yicheng 6
Genova 5
Hefei 5
Kunming 5
Malo 5
Markham 5
New York 5
Padova 5
Trento 5
Amsterdam 4
Berlin 4
Brugnera 4
Casoria 4
Chaoyang 4
Crotone 4
Ferrara 4
Fremont 4
Kemerovo 4
Melbourne 4
Monmouth Junction 4
Napoli 4
Novokuznetsk 4
Totale 16638
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 796
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 295
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 270
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 132
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 128
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 124
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 122
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 122
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 117
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 117
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 114
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 108
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 106
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 104
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 102
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 102
Chondroid syringoma with extensive ossification 102
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 101
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 100
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 99
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 98
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 98
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 97
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 96
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 96
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 95
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 94
Schwannoma del rene 92
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 92
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 92
CD10 is expressed in a subset of chromophobe renal cell carcinomas 90
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 90
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 90
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 90
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 90
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 89
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 89
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 88
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 87
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 87
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 87
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 85
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 85
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 85
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 85
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 85
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 85
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 84
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 84
Parvalbumin is constantly expressed in chromophobe renal carcinoma. 83
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 83
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 83
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 83
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 83
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 81
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 81
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 81
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 80
Adenocarcinoma of the paraurethral glands: a case report 80
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 80
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 80
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 80
Espressione di CD23 nelle neoplasie cutanee annessiali 79
Rapid screening for malignancy in organ donors. 15 years experience with the Verona "Alert" protocol and review of the literature 79
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma 77
Role of molecular markers in diagnosis and prognosis of renal cell carcinoma 77
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 77
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 77
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 77
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 77
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 77
Marcatori Diagnostici e Prognostici nei Tumori Renali 76
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 76
Significato prognostico della perdita del cromosoma 9P nei carcinomi renali a cellule chiare stratificati per UISS e SSIGN score 76
Pediatric optic nerve sheath meningioma 76
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 76
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 76
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 76
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 76
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 76
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 76
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 76
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 76
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 75
Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study 75
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 75
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 75
Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas 75
[Diagnostic and prognostic markers in renal tumors] 74
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 74
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 74
Interphase Cytogenetic in Metastatic Chromophobe Renal Cell Carcinoma (RCC) 73
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 73
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 73
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 73
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 73
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 73
Clear-Cell Papillary Renal cell Carcinoma: a Distinct Histopathological and Molecular Genetic Entity 73
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 72
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 72
Totale 9785
Categoria #
all - tutte 41346
article - articoli 35736
book - libri 0
conference - conferenze 5514
curatela - curatele 0
other - altro 96
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181679 0000 00 3451131 65247638
2018/20192313 6442449473 115186 43667 3730147240
2019/20203286 3566644223 296447 400181 177333308455
2020/20213742 351616231540 534355 105150 12462416258
2021/20223076 33373951338 150132 50208 9385232665
2022/20235463 4597726151188 6061737 860 0000
Totale 22417